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Abstract: We investigated the cytoprotective role of the dietary polyphenols on putative damage
induced by Amadori adducts in Human Peritoneal Mesothelial Cells (HPMCs). Increased
accumulation of early products of non-enzymatic protein glycation—Amadori adducts—in the
peritoneal dialysis fluid due to their high glucose, induces severe damage in mesothelial cells
during peritoneal dialysis. Dietary polyphenols reportedly have numerous health benefits in
various diseases and have been used as an efficient antioxidant in the context of several oxidative
stress-related pathologies. HPMCs isolated from different patients were exposed to Amadori
adducts (highly glycated haemoglobin, at physiological concentrations), and subsequently treated
with several polyphenols, mostly presented in our Mediterranean diet. We studied several
Amadori-induced effects in pro-apoptotic and oxidative stress markers, as well as the expression of
several pro-inflammatory genes (nuclear factor-kappaB, NF-kB; inducible Nitric Oxide synthetase,
iNOS), different caspase-activities, level of P53 protein or production of different reactive oxygen
species in the presence of different polyphenols. In fact, cytoprotective agents such as dietary
polyphenols may represent an alternate approach to protect mesothelial cells from the cytotoxicity of
Amadori adducts. The interference with the Amadori adducts-triggered mechanisms could represent
a therapeutic tool to reduce complications associated with peritoneal dialysis in the peritoneum,
helping to maintain peritoneal membrane function longer in patients undergoing peritoneal dialysis.
Keywords: polyphenols; Amadori adducts; apoptosis; highly glycosylated haemoglobin; human
mesothelial cells; reactive oxygen species; pro-inflammatory gene
1. Introduction
Peritoneal dialysis (PD) is an effective alternative method to haemodialysis in patients with
nephropathy and end-stage renal disease (ESRD) [1]. During PD, peritoneal dialysis fluids (PDF) have
shown cytotoxic effects based on their high glucose and lactate concentrations, the acidic pH, and
numerous toxic glucose degradation products (GDP) [2,3]. High concentrations of glucose impair
numerous cellular functions [4,5], including inducing non-enzymatic glycation of cell surface and
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interstitial matrix proteins. Non-enzymatic glycation involves the condensation reaction of a sugar with
a protein, resulting first in the rapid formation of a Schiff base, after which these adducts then undergo
rearrangements to stabilize the Amadori adducts. Only a small portion of these Amadori-adducts
undergoes further irreversible chemical reactions leading to the formation of advanced glycation
end-products (AGEs) [6,7]. The Amadori adducts or AGE transformation of proteins on the peritoneal
barrier, which is formed by mesothelial cells (MCs), induces loss of ultrafiltration capacity and increases
membrane permeability to low-molecular-weight solutions [8].
Over the last decade, we have shown that Amadori adducts, such as high glycated human
haemoglobin (HHb) and glycated bovine serum albumin (gBSA) may favour a pro-inflammatory
and pro-apoptotic state (called damage) in several cell types, such as aortic smooth, endothelial
and MCs [9–12]. Such damage effects, which involve reactive oxygen species, occur secondary to
exacerbated activity of the nitric oxide synthase (NOS) pathway with enhanced expression of several
nuclear factor-kB (NF-kB)-related proinflammatory genes [9–12]. Indeed, our data strongly support
the idea that long-term exposure of the peritoneum to high concentrations of glucose solutions during
PD maintains the peritoneum in a state of hyperglycaemia. This could act as an inducer of apoptosis in
MCs through Amadori adducts, involving different oxidative (ROS) and nitrosative (RNS) reactive
species [13,14]. Interference in this stress-induced environment may help to understand how to extend
PD in our patients.
Among different possible experimental approaches, the study of the effect of several polyphenols
has been reached in the last decade, due to i) a wide range of biological actions including their
anti-oxidant, anti-inflammatory, anti-cancer, and anti-microbial properties; and ii) their great abundance
in our Mediterranean diet and their role in the prevention of various diseases. In fact, continuous
and optimal intake of polyphenols has been associated with lower incidence of cancer, inflammation,
obesity, diabetes, cardiovascular disease (CVD), cognitive disorders and aging [15–20].
The mechanisms of action of polyphenols may be direct or indirect and have been reported
on their:
- anti-oxidant actions (such as scavenging radicals and metal ion chelation ability) [21].
- anti-inflammatory actions (through inhibition of the redox-sensitive transcription factors, such as
NF-kB and/or inhibition of “pro-oxidant” enzymes like inducible Nitric Oxide synthetase (iNOS),
COX, XO); induction of antioxidant enzymes, as glutathione S-transferase (GST and SOD) [22,23]
or acting as scavengers of reactive oxygen (ROS) and nitrogen (RNS) species and as chelators of
iron and copper, causal factors strictly correlated to inflammatory diseases [24–30].
- anti-glycation actions, mainly due to their antioxidant actions and carbonyl trapping functions [31–36].
In the present work, we study the effect of treatment with different polyphenols on oxidative
stress, apoptosis and inflammation induced by Amadori adducts in Human Peritoneal Mesothelial
Cells (HPMCs). Altogether, our results indicate that apoptosis of HPMCs induced by Amadori adducts
is inhibited with exposure to polyphenols, and may be associated with mobilization of anti-oxidative
and anti-inflammatory repair mechanisms.
2. Materials and Methods
2.1. Cell Culture
Human Peritoneal Mesothelial Cells, HPMCs, were isolated from omental tissue from 10 persons
(Table S1) undergoing non-urgent, non-septic abdominal surgery, using a previously described
method [9]. HPMCs were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing
10% foetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Sigma-Aldrich). Cell cultures
between passages two and five were used. The morphologic and immunofluorescence-staining features
of the cells remain stable during these passages (Table S2).
Antioxidants 2020, 9, 572 3 of 15
2.2. Preparation of Amadori Adducts
Commercial lyophilized non-enzymatically glycated human haemoglobin, containing either
normal (5.4%) HbA 1 level (NHb) or high (11.1%) HbA 1 level (HHb), was purchased from Sigma
Aldrich. Glycated solutions were prepared as previously described [9] (see supplementary data]).
The concentration of glycated solutions used, HHb and NHb 10 nM, is in the physiological range [37].
2.3. Polyphenols Administration
In this study, we evaluated the effects of natural, dietary, and common polyphenols on HPMCs. We
select these dietary polyphenols by focusing on their antioxidant, anti-inflammatory, and anti-glycation
activities. HPMCs were treated with four polyphenols: tannic acid (10 µM), resveratrol (12.5 µM),
quercetin (10 µM), and gallic acid (10 µM) (Sigma Aldrich). The selection of polyphenol concentrations
was based on previous studies [38–43]. In fact, the dose of polyphenols used was shown to be non-toxic
for cells, while other concentrations, of 15, 20, and 50 µM, induced cytotoxicity in HPMCs (data not
shown). Polyphenols solutions were prepared according to the manufacturer’s instructions.
Regarding the four polyphenols used, resveratrol is a polyphenolic phytoalexin belonging to
the stilbene family. It is a natural dietary plant compound that occurs mainly in grape skin and
seeds but is also found in wines and various other types of plant foods, especially peanuts, berries,
and tea [44]. Resveratrol reveals a wide range of biological properties including anti-glycation,
antioxidant, anti-inflammation, neuroprotective, anti-cancer, and anti-aging activity in various in vitro
and in vivo experimental models [45–49]. Quercetin is a great representative of polyphenols, flavonoids
subgroup, flavonols. Its main natural sources in foods are vegetables such as onions, the most studied
quercetin-containing foods, and broccoli; fruits (apples, berry crops, and grapes); some herbs; tea;
and wine. It is known for its antioxidant activity in radical scavenging [50]. In addition, quercetin
can efficiently inhibit glycation of DNA [51] as well as suppress α-dicarbonyl compound-induced
protein glycation [52,53], and possesses an anti-inflammatory potential that can be expressed on
different cell types, including human ones [54–59]. Gallic acid is found in some plants such as grape
seed, berries, rosaceous fruits, onion and tea leaves (green and black tea). Gallic acid possesses
strong free radical scavenging, antioxidant [60], anti-inflammatory, antibacterial, antiviral [61–63],
anticancer, anti-apoptotic [64,65] and anti-glycation [66] activities. Finally, tannic acid is a specific
form of tannin, which is widely distributed in green tea, wine, grapes, and plants. It has strong
antioxidant, anti-inflammatory, anticarcinogenic and antimutagenic activities [67] and anti-glycation
activities [68,69].
2.4. Intracellular Reactive Oxygen Species (ROS) Detection
To determine the presence of intracellular ROS, HPMCs seeded onto 96-well microplates were
grown to confluence and then serum-deprived for 24 h (0.5% FBS). HPMCs were then subjected to
the different treatments, and 2 h later the fluorescent probe dihydroethidine (DHE, Molecular Probes)
30 µM, was added to cell cultures for 90 min at 37 ◦C. Once inside the cell, DHE is able to fluoresce in the
presence of intracellular ROS. Intracellular fluorescence was then quantified using a microplate reader
GENios Plus (TECAN), using a previously described method [10]. In these and other experiments, the
Tempol (100 µM) is used like a cell-permeable nitroxide that acts as a free radical scavenger and nitric
oxide spin trap.
2.5. Determination of Caspases-3/7
For the quantitation of caspase-3/7 activity, a luminescent Caspase-Glo-3/7 Assay (Promega) was
used according to the manufacturer’s instructions and previously described method [13]. Luminescence
is proportional to the amount of caspase activity present and, for the purpose of comparison, 10µg total
protein was utilized. Luminescence was measured using a microplate reader GENios Plus (TECAN).
Z-DEVD-FMK (100 µM), a specific caspase-3 inhibitor, was also used.
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2.6. Quantitation of ATP-Levels
The CellTiter-Glo® Luminescent Cell Viability Assay is a homogeneous method based on
quantitation of the Adenosine triphosphate (ATP) present, which signals the presence of metabolically
active cells. Luminescence is proportional to the amount of ATP present and, for the purpose of
comparison, 10µg total protein was used to normalize results. ATP was measured following the
manufacturer’s protocol and previously described methods [70,71]. Luminescence was measured
using a microplate reader GENios Plus (TECAN).
2.7. Annexin V Detection by Indirect Immunofluorescence
Immunofluorescence examination was performed as described previously [13,72]. Briefly, HPMCs
cultures were fixed with 4% paraformaldehyde (PFA) and blocked for 1 h at 37 ◦C. Then, samples
were incubated overnight at 4 ◦C with a rabbit polyclonal anti-annexin V antibody (1/75; Abcam).
The following cells were incubated with secondary Alexa Fluor 546-conjugated goat anti-rabbit antibody
(1/250; Molecular Probes) for 45 min at 37 ◦C. Digital fluorescence microscopy was performed and
evaluated under an Olympus BX51 fluorescence microscope (Olympus). Fluorescence intensity was
quantified using the image analysis of software ImageJ (NIH). The specificity of the immunostaining
was evaluated by the omission of the primary antibody (negative controls).
2.8. Reporter Plasmids
The reporter plasmids p5xNF-kB-Luc and luciferase-based reporter plasmid corresponding to the
50-flanking regulatory regions of human iNOS (7.2 hiNOS-luc) were purchased from Stratagene, USA.
2.9. Transient Transfection
Transient transfection experiments were performed as we have previously described in
Peir selectfontó et al. 2003 [11]. Briefly, HPMCs (1 × 105 cells) were grown to 80–90% confluence.
The transfection mixture was added to cell cultures for an additional 18–20 h. The transfection mixture
consisted of 2 µg of the above-mentioned plasmids incubated with 75 µL of DMEM and 7.5 µL of
Superfects (Quiagen Gmbh, Germany) in vehicle medium, following the manufacturer’s instructions.
Following treatment with the specified agents, HPMCs were harvested and lysed with passive lysis buffer
(1×; Promega, USA), followed by one freeze/thaw cycle. The extracts were centrifuged and assayed with a
luciferase reporter system (Promega, USA). Luciferase activity was expressed as relative luciferase units
(RLUs) [11]. Results are normalized to protein content (1 µg).
2.10. Determination of p53 Levels
The p53 protein levels were measured in cell lysates using p53 commercial enzyme-linked
immune sorbent assay (ELISA) kits (Diaclone). After the development of the colorimetric reaction, the
absorbance was measured at 450 nm using a microplate reader (GENios Plus, TECAN). The levels of
p53 were normalized to protein content (5 µg).
2.11. Statistical Analysis
Results were expressed as mean ± SD (standard deviation). Statistical significance (p < 0.05) was
evaluated by factorial analysis of variance (ANOVA) with post hoc test, using the StatView statistics
program (Abacus Concepts Inc., Berkeley, CA, USA).
3. Results
3.1. Polyphenols Decrease Amadori-Induced ROS
The ability of polyphenols to inhibit intracellular ROS was assayed by measuring fluorescent probe
DHE in HPMC. Figure 1 shows that HHb (10 nM, physiological concentrations) significantly stimulates
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DHE fluorescence compared to baseline (B) or the presence of normally glycated haemoglobin form
(NHb, 10 nM). Interestingly, increased HHb-induced fluorescence was clearly reduced (by 50–60%)
in the presence of the different polyphenols used, in an analogous way to that of the intracellular
superoxide anionic scavenger Tempol (Figure 1). No significant differences in antioxidant activity were
observed between the different polyphenols.
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Figure 1. Polyphenols decrease reactive oxygen species induced by Amadori adducts. Representative 
experiments of the intracellular detection of superoxide anions over time using the fluorescence probe 
dihydroethidine (DHE). Human Peritoneal Mesothelial Cells (HPMCs) were treated with: HHb (10 
nM); NHb (10 nM); HHb (10 nM) + resveratrol (Resv, 12.5M); HHb (10 nM) + tannic acid (Tan, 10 
M); HHb (10 nM) + quercetin (Quer, 10 M); HHb (10 nM) + gallic acid (Gal, 10 M); or HHb (10 nM) 
+ Tempol (Temp, 100 M), a Reactive Oxygen Species (ROS) scavenger. For each experiment, 10 
independent cultures of HPMCs were used, corresponding to 10 donors. Data represent the mean ± 
SD of at least seven independent experiments (for each culture of HPMCs corresponding to each of 
the 10 donors) expressed as relative fluorescence units (RFUs). *p≤ 0.05 vs. basal. #p≤ 0.05 vs. HHb. 
3.2. Polyphenols Decrease iNOS Gene Expression and NF-kB-Dependent Transcription Induced by Amadori 
Adducts in HPMCs 
Next, we tested the ability of different polyphenols to reduce Amadori adducts-induced pro-
inflammatory gene expression. As we previously reported, the 24h HHb-stimulated iNOS promoter 
activity in HPMCs [9] was prevented in an appreciable way by different polyphenols (Figure 2A). 
Resveratrol and gallic acid may seem to have a more significant inhibitory effect on the iNOS 
promoter that quercetin and tannic acid. Tempol (100 μM) was used as a control inhibiting the action 
of HHb on the iNOS promoter. Similarly, Figure 2B shows that these polyphenols similarly inhibited 
HHb-induced NF-kB transcription-dependent in the HPMCs. 
 
Figure 1. Polyphenols decrease reactive oxygen species induced by Amadori adducts. Representative
experiments of the intracellular detection of superoxide anions over time using the fluorescence probe
dihydroethidine (DHE). Human Peritoneal Mesothelial Cells (HPMCs) were treated with: HHb (10 nM);
NHb (10 nM); HHb (10 nM) + resveratrol (Resv, 12.5 µM); HHb (10 nM) + tannic acid (Tan, 10 µM); HHb
(10 nM) + quercetin (Quer, 10 µM); HHb (10 nM) + gallic acid (Gal, 10 µM); or HHb (10 nM) + Tempol
(Temp, 100 µM), a Reactive Oxygen Species (ROS) scavenger. For each experiment, 10 independent
cultures of HPMCs were used, corresponding to 10 donors. Data represent the mean ± SD of at least
seven independent experiments (for each culture of HPMCs corresponding to each of the 10 donors)
expressed as relative fluorescence units (RFUs). * p ≤ 0.05 vs. basal. # p ≤ 0.05 vs. HHb.
3.2. Polyphenols Decrease iNOS Gene Expression and NF-kB-Dependent Transcription Induced by Amadori
Adducts in HPMCs
Next, we tested the ability of different polyphenols to reduce Amadori adducts-induced
pro-inflammatory gene expression. As we previously reported, the 24 h HHb-stimulated iNOS
pro oter activity in HPMCs [9] was prevented in an appreciable way by different polyphenols
(Figure 2A). Resveratrol and gallic acid may seem to have a more significant inhibitory effect on the
iNOS promoter that quercetin and tannic acid. Tempol (100 µM) was used as a control inhibiting the
action of HHb on the iNOS promoter. Similarly, Figure 2B shows that these polyphenols similarly
inhibited HHb-induced NF-kB transcription-dependent in the HPMCs.
3.3. Polyphenols Block Amadori-Induced Apoptosis in HPMCs
Figure 3A shows that polyphenols treatment is sufficient to cause a significant decrease in
caspase-3/7 activation after 24 h HHb exposure. No significant differences in the antiapoptotic action
of different polyphenols used were denoted. As a control, HHb-induced caspase-3/7 activation was
almost blunted by a specific caspase-3 inhibitor, ZDEVD-FMK (100 µM), and the ROS scavenger,
Tempol (100 µM), supporting the specificity of such effects (Figure 3A). We also measured ATP levels
(as an indicator of metabolic cell status) in whole protein HPMCs extracts. As expected, levels of
ATP in HPMCs treated with polyphenols were significantly higher than in HPMCs treated with HHb
(Figure 3B).
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Figure 2. Polyphenols decrease proinflammatory gene expression induced by Amadori products.
(A) The Human inducible Nitric Oxide synthetase (iNOS) promoter was studied using luciferase-based
reporter plasmids transiently transfected in HPMCs; (B) nuclear factor-kappaB (NF-kB)-dependent
transcriptional activation was assessed in cells transiently transfected with p5NF-kB-Luc plasmid.
HPMCs were treated HHb and NHb (both at 10 nM); polyphenols: resveratrol (Resv, 12.5 µM), tannic
acid (Tan, 10 µM), quercetin (Quer, 10 µM), gallic acid (Gal, 10 µM); or Tempol (Temp, 100 µM), a ROS
scavenger. For each experiment, 10 independent cultures of HPMCs were used, corresponding to
10 donors. Data represent the mean ± SD of at least seven independent experiments (for each culture of
HPMCs corresponding to each of the 10 donors) expressed as relative light units (RLUs). * p ≤ 0.05 vs.
basal. # p ≤ 0.05 vs. HHb.
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Figure 3. Polyphenols inhibit apoptosis induced by Amadori adducts in HPMCs. A) Caspase 3/7 
activity in whole cell lysates; B) ATP levels measured by a luminescent assay in HPMCs. Cells 
exposed for 24 h to different Amadori adducts, HHb and NHb (10 nM), polyphenols: resveratrol 
(Resv, 12.5M), tannic acid (Tan, 10 M), quercetin (Quer, 10 M), gallic acid (Gal, 10 M); Tempol 
(Temp, 100 M) a ROS scavenger and ZDEVD-FMK (100M), a specific caspase-3 inhibitor. For each 
experiment, 10 independent cultures of HPMCs were used, corresponding to 10 donors. Data 
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Figure 3. Polyphenols inhibit apoptosis induced by Amadori adducts in HPMCs. (A) Caspase 3/7
activity in whole cell lysates; (B) ATP levels measured by a luminescent assay in HPMCs. Cells exposed
for 24 h to different Amadori adducts, HHb and NHb (10 nM), polyphenols: resveratrol (Resv, 12.5 µM),
tannic acid (Tan, 10 µM), quercetin (Quer, 10 µM), gallic acid (Gal, 10 µM); Tempol (Temp, 100 µM)
a ROS scavenger and ZDEVD-FMK (100 µM), a specific caspase-3 inhibitor. For each experiment,
10 independent cultures of HPMCs were used, corresponding to 10 donors. Data represent means ± SD
of 7 independent experiments (for each culture of HPMCs corresponding to each of the 10 donors),
(A) in % and (B) in relative light units, RLUs, * p ≤ 0.05 vs. el basal. # p ≤ 0.05 vs. HHb.
3.4. Polyphenols Decrease Levels of Amadori Adducts-Induced Annexin V in HPMCs
Treatment of the HPMC cultures with HHb shows an increase in fluorescence, which is associated
with an increase of annexin-V, in the cells with respect to the polyphenol treatment groups (Figure 4)
at 24 h. After treatment with polyphenols, fluorescence intensity decreases in HPMCs with HHb,
therefore indicating a reduce apoptosis (Figure 4).
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on the protein levels of p53 in HPMC. As expected, HPMCs treated with HHb showed significantly 
increased p53 levels after 24 h of incubation (1.25±0.1, p≤ 0.05) (Figure 5). The results demonstrated 
that, compared with the HHb group, all polyphenols tested significantly decreased HHb-induced 
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Figure 4. Levels of annexin V decreased associated with Polyphenols treatment in HPMC.
(A) Representative immunostaining of annexin V in HPMCs. The cytoplasm shows annexin-positive
staining (red) characteristic of apoptotic cells (×40). Scale bar 100 µm; (B) Quantification of fluorescence
intensity for Annexin-V. Cells exposed for 24 h to different Amadori adducts, HHb and NHb (10 nM),
polyphenols: resveratrol (Resv, 12.5 µM), tannic acid (Tan, 10 µM), quercetin (Quer, 10 µM), gallic acid (Gal,
10 µM). For each experiment, 10 independent cultures of HPMCs were used, corresponding to 10 donors.
Data represent means ± SD of 7 independent experiments (for each culture of HPMCs corresponding to
each of the 10 donors), (B) in Arbitrary units (AU), * p ≤ 0.05 vs. el basal. # p ≤ 0.05 vs. HHb.
3.5. Polyphenols Decrease Tumour Suppressor Protein p53 Levels Induced by Amadori Adducts
Tumor suppressor p53 has been shown to modulate apoptosis. We examined the effect of HHb
on the protein levels of p53 in HPMC. As expected, HPMCs treated with HHb showed significantly
increased p53 levels after 24 h of incubation (1.25 ± 0.1, p ≤ 0.05) (Figure 5). The results demonstrated
that, compared with the HHb group, all polyphenols tested significantly decreased HHb-induced p53
levels (Resv, 1.02± 0.1; Quer, 1.09± 0.24; Tan, 1.09± 0.14; and Gal, 1.04± 0.1) (Figure 5). A concentration
of 25 mM glucose (HGl, High Glucose) was used as a p53 stimulation control (1.45± 0.06 times induction
on the basal).
Antioxidants 2020, 9, 572 9 of 15
Antioxidants 2020, 9, x FOR PEER REVIEW 9 of 16 
                    
Figure 5. Polyphenols decrease tumour suppressor protein p53 levels induced by Amadori Adducts. 
Cells exposed for 24 h to different Amadori adducts, HHb and NHb (10 nM), polyphenols: resveratrol 
(Resv, 12.5M), tannic acid (Tan, 10 M), quercetin (Quer, 10 M), gallic acid (Gal, 10 M); and 25 mM 
glucose (HGl, High Glucose). For each experiment, 10 independent cultures of HPMCs were used, 
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instance, the interactions between tannins and proteins are associated with hydrogen bonding, 
hydrophobic interactions based on van der Waals forces, and the repelling of water, and 
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Figure 5. Polyphenols decrease tumour suppressor protein p53 levels induced by Amadori Adducts.
Cells exposed for 24 h to different Amadori adducts, HHb and NHb (10 nM), polyphenols: resveratrol
(Resv, 12.5 µM), tannic acid (Tan, 10 µM), quercetin (Quer, 10 µM), gallic acid (Gal, 10 µM); and 25 mM
glucose (HGl, High Glucose). For each experiment, 10 independent cultures of HPMCs were used,
corresponding to 10 donors. Data represent means ± SD of 7 independent experiments (for each culture
of HPMCs corresponding to each of the 10 donors), * p ≤ 0.05 vs. el basal. # p ≤ 0.05 vs. HHb.
4. Discussion
Previous studies by our laboratory and others indicate that the Amadori adducts, such as
HHb, could induce effects in vascular and mesothelial cells similar to those induced by AGEs,
such as to bring about endothelial dysfunction [15], and activate different proinflammatory and/or
pro-apoptotic markers in HPMCs [9,13]. We proposed that the use of different diet polyphenols might
protect mesothelial cells against Amadori adducts cytotoxicity, and exert significant protection against
apoptosis, oxidative stress, and inflammation. These polyphenols, based on all effects presented,
must have a beneficial role for patients undergoing PD, although additional in vivo experiments
may have to verify this hypothesis. However, several facts may support this idea, Amadori-albumin
has been demonstrated in the glomeruli of patients with diabetic nephropathy, and the degree of
staining was increased with the severity of tissue damage [73]. These findings are consistent with a
role of Amadori-albumin in the development of nephropathy. It is worth noting that early glycated
proteins can be incorporated into mesothelial cells by a transcytosis mechanism [74]. In addition,
our previous data pointed to long-term hyperglycaemia acting as an inducer of apoptosis in HPMCs
through Amadori adducts, involving different oxidative and nitrosative reactive species [9,11–13]
Polyphenols constitute one of the most numerous secondary metabolites present in all
commonly consumed dietary vegetables [75–78]. Polyphenols are reported to have numerous health
benefits [75–78]. We have herein delineated the mechanisms by which polyphenols inhibit apoptosis in
HPMCs, involving a significant decrease of oxidative stress induced by Amadori adducts. We also
hypothesize that one of the protective echanis s of polyphenols is that they could be oxidized by a
direct reaction with free radicals. During this reaction, the free radicals are stabilized, and the active
oxygen species are directly eliminated. In fact, polyphenols’ ability to inhibit the protein glycation
are correlated to their free-radical scavenging capacity, suggesting that the inhibitory mechanism is,
at least partly, due to their antioxidant property [79]. In addition, there exists the possibility that
these plant polyphenols directly bind to proteins, as has been suggested [80], inhibiting the binding of
sugars to these protein substrates and suppressing the promotion of the Maillard reaction. For instance,
the interactions between tannins and proteins are associated with hydrogen bonding, hydrophobic
interactions based on van der Waals forces, and the repelling of water, and polymerization generally
intensifies the tannic effects [81]. The involvement of the carboxyl group and its steric structure, as
well as the degree of polymerization, likely inhibits the Maillard reaction [81].
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Additionally, our data also point out that polyphenols exert anti-inflammatory effects through
molecular mechanisms such as inhibition of the redox-sensitive transcription factor NF-kB and
inhibition of “pro-oxidant” enzyme iNOS, at least in molecular gene expression. It is widely known
that polyphenols exert the anti-inflammatory action by different mechanisms: radical scavenging,
metal chelating, NOS inhibition, inhibition of certain enzymes involved in ROS production, and
upregulation of endogenous antioxidant enzymes [42,75–77,80]. This work is in agreement with
previous studies, which support the preventive effects of polyphenols on inflammation in different
diseases [39,48,82–84], including the kidney in animal models [85] or in vivo models of study, where
active compounds extracted from extra olive oil (oil phenols) counteract mesothelial to mesenchymal
transition of HPMCs exposed to conventional peritoneal dialysate in vitro and in vivo, preventing
and counteracting the development of peritoneal fibrosis during PD [86,87]. These data are consistent
with the results obtained by other groups, for example, when immortalized human mesothelial cells
(Met5A) were exposed either to the regular growth medium, to standard acidic lactate-buffered PDF
(Dianeal PD4), or to a more biocompatible lactate-bicarbonate-buffered PDF (Physioneal 40). In the
presence of quercetin, which induced cytoprotection, potentially based on its antioxidant effects in
this model [88]. Chong-Ting et al. (2016) demonstrated that supplementation with trans-resveratrol
improved ultrafiltration in PD patients, and high-dose supplementation may improve ultrafiltration
by ameliorating angiogenesis induced by conventional lactate-buffered PD solutions [89]. In another
study, Firuzi et al. (2016) concluded that silymarin could be considered a complementary therapy to
reduce PD-related complications in patients with ESRD undergoing PD. Silymarin is a standardized
extract of the herb milk thistle, Silybum marianum. It consists of flavonolignans (polyphenols) including
silybin, silydianin, and silychristine. Of these, silybin is the component with the highest biological
activity [90]. Other groups observed that the decrease in inflammatory cytokines delayed the onset of
diabetic nephropathy [91,92].
On the other hand, results improving the biocompatibility of peritoneal dialysis fluids (PDF)
blocking oxidation and glycation on those PDFs, clearly reduce cell damage of glucose degradation
products in PD patients [93]. The results presented herein in our study, an in vitro model, are
strengthened by different studies that demonstrated the beneficial effects of polyphenols in patients
receiving PD.
5. Conclusions
In conclusion, our study showed that cytoprotective agents such as polyphenols may represent
an alternate approach to protect mesothelial cells from the cytotoxicity of Amadori adducts. Future
studies will be needed to elucidate the in vivo effects of this approach. Therefore, interfering with
the signaling mechanisms triggered by Amadori adducts could represent a therapeutic tool to reduce
complications associated with exposure to PDF in the peritoneum. Indeed, polyphenols may help to
maintain peritoneal membrane function longer in patients undergoing PD. Regular, daily consumption
of polyphenols, in the form of food or extracts, may aid in the prevention or inhibition of non-enzymatic
amino acid glycation in the living body. Non-enzymatic amino acid glycation may be associated with
ageing, diabetic complications, and other diseases.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/9/7/572/s1.
Table S1: Characteristics of the patients, mean age 54.66 ± 5.08; range 23–79 yrs. * Patients with a diagnosis of
cancer were free of metastatic disease and peritoneal involvement, Table S2: HPMC characterization
Author Contributions: Conceptualization, J.N., L.R.-M. and C.P.; methodology, J.N., C.P. and C.S.-R.; software, J.N.;
validation, J.N. and C.S.-R.; formal analysis, J.N. and C.S.-R.; investigation, C.S.-R.; resources, J.N.; data curation,
J.N.; writing—original draft preparation, C.S.-R.; writing—review and editing, J.N. and C.S.-R.; visualization, J.N.
and C.S.-R.; supervision, J.N.; project administration, J.N.; funding acquisition, J.N. All authors have read and
agreed to the published version of the manuscript.
Funding: This research was funded by FIS: 01/0579; 04/1839. CSR was a recipient of a research contract from
PI04/1839 and CA08/00324 of ISCIII.
Acknowledgments: We are grateful to Eva López for her comments on this manuscript.
Antioxidants 2020, 9, 572 11 of 15
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Kuo, H.; Chen, H.; Hsiao, H.; Chen, H. Heat shock response protects human peritoneal mesothelial cells
from dialysate-induced oxidative stress and mitochondrial injury. Nephrol. Dial. Transpl. 2009, 24, 1799–1809.
[CrossRef] [PubMed]
2. Büchel, J.; Bartosova, M.; Eich, G.; Wittenberger, T.; Klein-Hitpass, L.; Steppan, S.; Hackert, T.; Schaefer, F.;
Passlick-Deetjen, J.; Schmitt, C.P. Interference of peritoneal dialysis fluids with cell cycle mechanisms. Perit.
Dial. Int. 2015, 35, 259–274. [CrossRef]
3. Boehm, M.; Bergmeister, H.; Kratochwill, K.; Vargha, R.; Lederhuber, H.; Aufricht, C. Cellular stress-response
modulators in the acute rat model of peritoneal dialysis. Pediatr. Nephrol. 2010, 25, 169–172. [CrossRef]
[PubMed]
4. Lee, H.B.; Yu, M.R.; Song, J.S.; Ha, H. Reactive oxygen species amplify protein kinase C signaling in high
glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int. 2004, 65, 1170–1179.
[CrossRef] [PubMed]
5. Ha, H.; Cha, M.K.; Choi, H.N.; Lee, H.B. Effects of peritoneal dialysis solutions on the secretion of growth
factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit. Dial. Int. 2002, 22,
171–177. [CrossRef] [PubMed]
6. Khangholi, S.; Majid, F.A.; Berwary, N.J.; Ahmad, F.; Aziz, R.B. The Mechanisms of Inhibition of Advanced
Glycation End Products Formation through Polyphenols in Hyperglycemic Condition. Planta Med. 2016, 82,
32–45. [CrossRef] [PubMed]
7. Baynes, J.W.; Thorpe, S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med. 2000, 28,
1708–1716. [CrossRef]
8. Honda, K.; Nitta, K.; Horita, S.; Yumura, W.; Nihei, H.; Nagai, R.; Ikeda, K.; Horiuchi, S. Accumulation of
advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis
patients with low ultra-filtration. Nephrol. Dial. Transplant 1999, 14, 1541–1549. [CrossRef]
9. Nevado, J.; Peiró, C.; Vallejo, S.; El-Assar, M.; Lafuente, N.; Matesanz, N.; Azcutia, V.; Cercas, E.;
Sánchez-Ferrer, C.F.; Rodríguez-Mañas, L. Amadori adducts activate NF-kB-related pro-inflammatory
genes in human peritoneal mesothelial cells. Br. J. Pharmacol. 2005, 146, 268–279. [CrossRef]
10. Peiró, C.; Lafuente, N.; Matesanz, N.; Cercas, E.; Llergo, J.L.; Vallejo, S.; Rodríguez-Mañas, L.;
Sánchez-Ferrer, C.F. High glucose induces cell death of cultured human aortic smooth muscle cells through
the formation of hydrogen peroxide. Br. J. Pharmacol. 2001, 133, 967–974.
11. Peiro, C.; Matesanz, N.; Nevado, J.; Lafuente, N.; Cercas, E.; Azcutia, V.; Vallejo, S.; Rodriguez-Manas, L.;
Sanchez-Ferrer, C.F. Glycosylated human oxyhaemoglobin activates nuclear factor-kappaB and activator
protein-1 in cultured human aortic smooth muscle. Br. J. Pharmacol. 2003, 140, 681–690. [CrossRef] [PubMed]
12. Rodríguez-Mañas, L.; Angulo, J.; Vallejo, S.; Sánchez-Ferrer, A.; Cercas, E.; López-Dóriga, P.;
Sánchez-Ferrer, C.F. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial
dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia 2003, 46, 556–566. [CrossRef]
[PubMed]
13. Sánchez-Rodríguez, C.; Peiró, C.; Vallejo, S.; Matesanz, N.; El-Assar, M.; Azcutia, V.; Romacho, T.;
Sánchez-Ferrer, C.F.; Rodríguez-Mañas, L.; Nevado, J. Pathways Responsible for Apoptosis Resulting
from Amadori-Induced Oxidative and Nitrosative Stress in Human Mesothelial Cells. Am. J. Nephrol. 2011,
34, 104–114.
14. Amore, A.; Cirina, P.; Conti, G.; Cerutti, F.; Bagheri, N.; Emancipator, S.N.; Coppo, R. Amadori-configurated
albumin induces nitric oxide-dependent apoptosis of endothelial cells: A possible mechanism of diabetic
vasculopathy. Nephrol. Dial. Transpl. 2004, 19, 53–60. [CrossRef] [PubMed]
15. Amore, A.; Cirina, P.; Conti, G.; Cerutti, F.; Bagheri, N.; Emancipator, S.N.; Coppo, R. Icodextrin avoids
the enhancement of inducible nitric oxide (iNOS) activity in peritoneal mesothelial cells given by glucose
solutions. J. Am. Soc. Nephrol. 1998, 9, 278.
16. Drel, V.R.; Sybirna, N. Protective effects of polyphenolics in red wine on diabetes associated oxidative/nitrative
stress in streptozotocindiabetic rats. Cell Biol. Int. 2010, 34, 1147–1153. [CrossRef]
Antioxidants 2020, 9, 572 12 of 15
17. Del Rio, D.; Borges, G.; Crozier, A. Berry flavonoids and phenolics: Bioavailability and evidence of protective
effects. Br. J. Nutr. 2010, 104, S67–S90. [CrossRef]
18. Konic-Ristic, A.; Kroon, P.A.; Glibetic, M. Modulation of platelet function with dietary polyphenols:
A promising strategy in the prevention of cardiovascular disease. Agro Food Ind. Hi Tech 2015, 26, 15–19.
19. Rodriguez-Mateos, A.; Vauzour, D.; Krueger, C.G.; Shanmuganayagam, D.; Reed, J.; Calani, L.; Mena, P.;
Del Rio, D.; Crozier, A. Bioavailability, bioactivity and impact on health of dietary flavonoids and related
compounds: An update. Arch. Toxicol. 2014, 88, 1803–1853. [CrossRef] [PubMed]
20. Vauzour, D.; Rodriguez-Mateo, A.; Corona, G.; Oruna-Concha, M.J.; Spencer, J.P.E. Polyphenols and human
health: Prevention of disease and mechanisms of action. Nutrients 2010, 2, 1106–1131. [CrossRef]
21. Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J. Flavonoid antioxidants: Chemistry, metabolism and
structure-activity relationships. J. Nutr. Biochem. 2002, 13, 572–584. [CrossRef]
22. Tak, P.P.; Firestein, G.S. NF-kB: A key role in inflammatory diseases. J. Clin. Investig. 2001, 107, 7–11.
[CrossRef] [PubMed]
23. Frei, B.; Higdon, J.V. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr.
2003, 133, 3275S–3284S. [CrossRef] [PubMed]
24. Stevenson, D.E.; Hurst, R.D. Polyphenolic phytochemicals–just antioxidants or much more. Cell. Mol. Life
Sci. 2007, 64, 2900–2916. [CrossRef]
25. Pashkow, F.J.; Watumull, D.G.; Campbell, C.L. Astaxanthin: A novel potential treatment for oxidative stress
and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101, S58–S68. [CrossRef]
26. Chung, H.Y.; Cesari, M.; Anton, S.; Marzetti, E.; Giovannini, S.; Young Seo, A.; Carter, C.; Pal Yu, B.;
Leeuwenburgh, C. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res.
Rev. 2009, 8, 18–30. [CrossRef] [PubMed]
27. Durackova, Z. Some current insights into oxidative stress. Physiol. Res. 2010, 59, 459.
28. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How
are they linked? Free Radic. Biol. Med. 2010, 49, 1603–1616. [CrossRef]
29. Varga, Z.V.; Giricz, Z.; Liaudet, L.; Haskó, G.; Ferdinandy, P.; Pacher, P. Interplay of oxidative,
nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim.
Biophys. Acta Mol. Basis Dis. 2015, 1852, 232–242. [CrossRef]
30. Maurya, P.K.; Noto, C.; Rizzo, L.B.; Rios, A.C.; Nunes, S.O.; Barbosa, D.S.; Sethi, S.; Zeni, M.; Mansur, R.B.;
Maes, M.; et al. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder.
Prog. Neuro-Psychopharmacol. Biol. Psychiat. 2016, 65, 134–144. [CrossRef]
31. Zhang, X.; Chen, F.; Wang, M. Antioxidant and antiglycation activity of selected dietary polyphenols in a
cookie model. J. Agric. Food Chem. 2014, 62, 1643–1648. [CrossRef]
32. Guerra, P.V.; Yaylayan, V.A. Interaction of Flavanols with Amino Acids: Postoxidative Reactivity of the
B-ring of Catechin with Glycine. J. Agric. Food Chem. 2014, 62, 3831–3836. [CrossRef]
33. Sang, S.; Shao, X.; Bai, N.; Lo, C.Y.; Yang, C.S.; Ho, C.T. Tea polyphenol (-)-epigallocatechin-3-gallate: A new
trapping agent of reactive dicarbonyl species. Chem. Res. Toxicol. 2007, 20, 1862–1870. [CrossRef]
34. Yin, J.; Hedegaard, R.V.; Skibsted, L.H.; Andersen, M.L. Epicatechin and Epigallocatechin Gallate Inhibit
Formation of Intermediary Radicals during Heating of Lysine and Glucose. Food Chem. 2014, 146, 48–55.
[CrossRef] [PubMed]
35. Silvan, J.M.; Srey, C.; Ames, J.M.; del Castillo, M.D. Glycation Is Regulated by Isoflavones. Food Funct. 2014,
5, 2036–2042. [CrossRef] [PubMed]
36. Ramkissoon, J.S.; Mahomoodally, M.F.; Ahmed, N.; Subratty, A.H. Antioxidant and anti-glycation activities
correlates with phenolic composition of tropical medicinal herbs. Asian Pac. J. Trop. Med. 2013, 6, 561–569.
[CrossRef]
37. Tietz, N.W. Clinical Guide to Laboratory Tests; WB Saunders: Philadelphia, PA, USA, 1990; pp. 284–285.
38. Ferruelo, A.; Romero, I.; Cabrera, P.M.; Arance, I.; Andrés, G.; Angulo, J.C. Effects of resveratrol and other
wine polyphenols on the proliferation, apoptosis and androgen receptor expression in LNCaP cells. Actas
Urol. Esp. 2014, 38, 397–404. [CrossRef] [PubMed]
39. Ferruelo, A.; de Las Heras, M.M.; Redondo, C.; de Fata, F.R.; Romero, I.; Angulo, J.C. Wine polyphenols exert
antineoplasic effect on androgen resistant PC-3 cell line through the inhibition of the transcriptional activity
of COX-2 promoter mediated by NF-kβ. Actas Urol. Esp. 2014, 38, 429–437. [CrossRef]
Antioxidants 2020, 9, 572 13 of 15
40. Mrvová, N.; Skandík, M.; Kuniaková, M.; Racková, L. Modulation of BV-2 microglia functions by novel
quercetin pivaloyl ester. Neurochem. Int. 2015, 90, 246–254. [CrossRef]
41. Ramyaa, P.; Krishnaswamy, R.; Padma, V.V. Quercetin modulates OTA-induced oxidative stress and redox
signaling in HepG2 cells—up regulation of Nrf2 expression and down regulation of NF-κB andCOX-2.
Biochim. Biophys. Acta Gen. Subj. 2014, 1840, 681–692. [CrossRef]
42. Ma, C.; Wang, Y.; Dong, L.; Li, M.; Cai, W. Anti-inflammatory effect of resveratrol through the suppression
of NF-κB and JAK/STAT signaling pathways. Acta Biochim. Biophys. Sin. 2015, 47, 207–213. [CrossRef]
[PubMed]
43. Li, Y.; Yao, J.; Han, C.; Yang, J.; Chaudhry, M.T.; Wang, S.; Liu, H.; Yin, Y. Quercetin, Inflammation and
Immunity. Nutrients 2016, 8, 167. [CrossRef]
44. Shrikanta, A.; Kumar, A.; Govindaswamy, V. Resveratrol Content and Antioxidant Properties of Underutilized
Fruits. J. Food Sci. Technol. 2015, 52, 383–390. [CrossRef] [PubMed]
45. Öztürk, E.; Arslan, A.K.K.; Yerer, M.B.; Bishayee, A. Resveratrol and diabetes: A critical review of clinical
studies. Biomed. Pharmacother. 2017, 95, 230–234. [CrossRef] [PubMed]
46. Rauf, A.; Imran, M.; Suleria, H.A.R.; Ahmad, B.; Peters, D.G.; Mubarak, M.S. A comprehensive review of the
health perspectives of resveratrol. Food Funct. 2017, 8, 4284–4305. [CrossRef] [PubMed]
47. Jardim, F.R.; de Rossi, F.T.; Nascimento, M.X.; Gabriele da Silva Barros, R.; Agrizzi Borges, P.; Cristina
Prescilio, I.; Roberto de Oliveira, M. Resveratrol and Brain Mitochondria: A Review. Mol. Neurobiol. 2018, 55,
2085–2101. [CrossRef]
48. Li, Y.R.; Li, S.; Lin, C.C. Effect of resveratrol and pterostilbene on aging and longevity. Biofactors 2018, 44,
69–82. [CrossRef]
49. Salehi, B.; Mishra, A.P.; Nigam, M.; Sener, B.; Kilic, M.; Sharifi-Rad, M.; Fokou, P.V.T.; Martins, N.; Sharifi-Rad, J.
Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines 2018, 6, 91. [CrossRef]
50. Spencer, J.P.; Kuhnle, G.G.; Williams, R.J.; Rice-Evans, C. Intracellular metabolism and bioactivity of quercetin
and its in vivo metabolites. Biochem. J. 2003, 372, 173–181. [CrossRef]
51. Sengupta, B.; Uematsu, T.; Jacobsson, P.; Swenson, J. Exploring the antioxidant property of bioflavonoid
quercetin in preventing DNA glycation: A calorimetric and spectroscopic study. Biochem. Biophys. Res.
Commun. 2006, 339, 355–361. [CrossRef]
52. Wang, P.; Heber, D.; Henning, S.M. Quercetin increased bioavailability and decreased methylation of green
tea polyphenols in vitro and in vivo. Food Funct. 2012, 3, 635–642. [CrossRef]
53. Hsieh, C.L.; Peng, C.H.; Chyau, C.C.; Lin, Y.C.; Wang, H.E.; Peng, R.Y. Low-density lipoprotein, collagen,
and thrombin models reveal that Rosemarinus officinalis L. exhibits potent antiglycative effects. J. Agric.
Food Chem. 2007, 55, 2884–2891. [CrossRef] [PubMed]
54. Gerates, L.; Moonen, H.J.J.; Brauers, K.; Wouters, E.F.M.; Bast, A.; Hageman, G.J. Dietary flavones and
flavonols are inhibitor of poly (ADP-ribose) polymerase-1 in pulmonary epithelial cells. J. Nutr. 2007, 137,
2190–2195. [CrossRef]
55. Bureau, G.; Longpre, F.; Martinoli, M.G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic
neuronal cell death induced by neuroinflammation. J. Neurosci. Res. 2008, 86, 403–410. [CrossRef]
56. Lee, K.M.; Hwang, M.K.; Lee, D.E.; Lee, K.W.; Lee, H.J. Protective effect of quercetin against arsenite-induced
COX-2 expression by targeting PI3K in rat liver epithelial cells. J. Agric. Food Chem. 2010, 58, 815–5820.
[CrossRef] [PubMed]
57. Endale, M.; Park, S.C.; Kim, S.H.; Yang, Y.; Cho, J.Y.; Rhee, M.H. Quercetin disrupts tyrosine-phosphorylated
phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1
and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology 2013, 218,
1452–1467. [CrossRef] [PubMed]
58. Kempuraj, D.; Madhappan, B.; Christodoulou, S.; Boucher, W.; Cao, J.; Papadopoulou, N.; Cetrulo, C.L.;
Theoharides, T.C. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and
protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol. 2005, 145, 934–944. [CrossRef]
59. Yang, D.; Liu, X.; Liu, M.; Chi, H.; Liu, J.; Han, H. Protective effects of quercetin and taraxasterol against
H2O2 -induced human umbilical vein endothelial cell injury in vitro. Exp. Ther. Med. 2015, 10, 1253–1260.
[CrossRef] [PubMed]
Antioxidants 2020, 9, 572 14 of 15
60. Priscilla, D.H.; Mainzen-Prince, P.S. Cardio protective effect of gallic acid on cardiac troponin-T, cardiac
marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial
infarction in Wistar rats. Chem. Biol. Interact. 2009, 179, 118–124. [CrossRef]
61. Kim, S.H.; Jun, C.D.; Suk, K. Gallic acid inhibits histamine release and pro-inflammatory cytokine production
in mast cells. Toxicol. Sci. 2006, 91, 123–131. [CrossRef]
62. Kang, M.S.; Oh, J.S.; Kang, I.C.; Hong, S.-J.; Choi, C.-H. Inhibitory effect of methyl gallate and Gallic Acid on
oral bacteria. J. Microbiol. 2008, 46, 744–750. [CrossRef]
63. Kratz, J.M.; Andrighetti-Fröhner, C.R.; Leal, P.C.; Nunes, R.J.; Yunes, R.A.; Trybala, E.; Bergström, T.;
Barardi, C.R.; Simões, C.M. Evaluation of anti-HSV-2 activity of Gallic Acid and pentylgallate. Biol. Pharm.
Bull. 2008, 31, 903–907. [CrossRef] [PubMed]
64. Faried, A.; Kurnia, D.; Faried, L.S.; Usman, N.; Miyazaki, T.; Kato, H.; Kuwano, H. Anticancer effects of gallic
acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines.
Int. J. Oncol. 2007, 30, 605–613. [CrossRef] [PubMed]
65. Sameermahmood, Z.; Raji, L.; Saravanan, T.; Vaidya, A.; Mohan, V.; Balasubramanyam, M. Gallic acid
protects RINm5F beta-cells from glucolipotoxicity by its antiapoptotic and insulin-secretagogue actions.
Phytother. Res. 2010, 24, 83–94. [CrossRef] [PubMed]
66. Umadevi, S.; Gopi, V.; Elangovan, V. Regulatory Mechanism of Gallic Acid Against Advanced Glycation
End Products Induced Cardiac Remodeling in Experimental Rats. Chem. Biol. Interact. 2014, 208, 28–36.
[CrossRef]
67. Ahmad, S.T.; Sultana, S. Tannic acid mitigates cisplatin-induced nephrotoxicity in mice. Hum. Exp. Toxicol.
2012, 31, 145–156. [CrossRef]
68. Karuppagounder, V.; Arumugam, S.; Thandavarayan, R.A.; Pitchaimani, V.; Sreedhar, R.; Afrin, R.; Harima, M.;
Suzuki, H.; Nomoto, M.; Miyashita, S.; et al. Tannic acid modulates NFκB signaling pathway and skin
inflammation in NC/Nga mice through PPARγ expression. Cytokine 2015, 76, 206–213. [CrossRef]
69. Huang, Q.; Chai, W.M.; Ma, Z.Y.; Ou-Yang, C.; Wei, Q.-M.; Song, S.; Zou, Z.-R.; Peng, Y.-Y. Inhibition
of α-glucosidase activity and non-enzymatic glycation by tannic acid: Inhibitory activity and molecular
mechanism. Int. J. Biol. Macromol. 2019, 141, 358–368. [CrossRef]
70. Nevado, J.; Sanz, R.; Casqueiro, J.C.; Ayala, A.; García-Berrocal, J.R.; Ramírez-Camacho, R. Ageing evokes an
intrinsic pro-apoptotic signalling pathway in rat cochlea. Acta Otolaryngol. 2006, 126, 1134–1139. [CrossRef]
71. García-Berrocal, J.R.; Nevado, J.; Ramírez-Camacho, R.; Sanz, R.; González-García, J.A.; Sánchez-Rodríguez, C.;
Cantos, B.; España, P.; Verdaguer, J.M.; Trinidad Cabezas, A. The anticancer drug cisplatin induces an intrinsic
apoptotic pathway inside the inner ear. Br. J. Pharmacol. 2007, 152, 1012–1020. [CrossRef]
72. Benevolensky, D.; Belikova, Y.; Mohammadzadeh, R.; Trouvé, P.; Marotte, F.; Russo-Marie, F.; Samuel, J.L.;
Charlemagne, D. Expression and localization of the annexins II, V, and VI in myocardium from patients with
end-stage heart failure. Lab. Investig. 2000, 80, 123–133. [CrossRef]
73. Neelofar, K.; Ahmad, J. Amadori albumin in diabetic nephropathy. Indian J. Endocrinol. Metab. 2015, 19,
39–46.
74. Bodega, F.; Zocchi, L.; Agostoni, E. Albumin transcytosis in mesothelium. Am. J. Physiol. Lung Cell. Mol.
Physiol. 2002, 282, L3–L11. [CrossRef]
75. Kujawska, M.; Jodynis-Liebert, J. Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo
Studies. Nutrients 2018, 10, 642. [CrossRef] [PubMed]
76. Serino, A.; Salazar, G. Protective Role of Polyphenols against Vascular Inflammation, Aging and
Cardiovascular Disease. Nutrients 2018, 11, 53. [CrossRef] [PubMed]
77. Niedzwiecki, A.; Roomi, M.W.; Kalinovsky, T.; Rath, M. Anticancer Efficacy of Polyphenols and Their
Combinations. Nutrients 2016, 8, 552. [CrossRef] [PubMed]
78. Albertoni, G.; Schor, N. Resveratrol plays important role in protective mechanisms in renal
disease–mini-review. J. Bras. Nefrol. 2015, 37, 106–114. [CrossRef] [PubMed]
79. Crascì, L.; Lauro, M.R.; Puglisi, G.; Panico, A. Natural antioxidant polyphenols on inflammation management:
Anti-glycation activity vs. metalloproteinases inhibition. Crit. Rev. Food Sci. Nutr. 2018, 58, 893–904.
[CrossRef]
80. Wei, J.; Jin, F.; Wu, Q.; Jiang, Y.; Gao, D.; Liu, H. Molecular interaction study of flavonoid derivative 3d
with human serum albumin using multi spectroscopic and molecular modeling approach. Talanta 2014, 126,
116–121. [CrossRef] [PubMed]
Antioxidants 2020, 9, 572 15 of 15
81. Richard, T.; Lefeuvre, D.; Descendit, A.; Quideau, S.; Monti, J.P. Recognition characters in peptide-polyphenol
complex formation. Biochim. Biophys. Acta 2006, 1760, 951–958. [CrossRef] [PubMed]
82. Zhao, X.J.; Yu, H.W.; Yang, Y.Z.; Wu, W.Y.; Chen, T.Y.; Jia, K.K.; Kang, L.L.; Jiao, R.Q.; Kong, L.D. Polydatin
prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate
Keap1/Nrf2 pathway. Redox Biol. 2018, 18, 124–137. [CrossRef] [PubMed]
83. Bereswill, S.; Muñoz, M.; Fischer, A.; Plickert, R.; Haag, L.M.; Otto, B.; Kühl, A.A.; Loddenkemper, C.;
Göbel, U.B.; Heimesaat, M.M. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute
small intestinal inflammation. PLoS ONE 2010, 5, e15099. [CrossRef] [PubMed]
84. Švajger, U.; Jeras, M. Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of
Immune-Mediated Diseases. Int. Rev. Immunol. 2012, 31, 202–222. [CrossRef] [PubMed]
85. Yousuf, M.J.; Vellaichamy, E. Protective Activity of Gallic Acid Against Glyoxal -Induced Renal Fibrosis in
Experimental Rats. Toxicol. Rep. 2015, 2, 1246–1254. [CrossRef]
86. Lupinacci, S.; Perri, A.; Toteda, G.; Vizza, D.; Puoci, F.; Parisi, O.I.; Giordano, F.; Lofaro, D.; La Russa, A.;
Bonofiglio, M.; et al. Olive leaf extract counteracts epithelial to mesenchymal transition process induced by
peritoneal dialysis, through the inhibition of TGFβ1 signaling. Cell Biol. Toxicol. 2018, 35, 95–109. [CrossRef]
87. Lupinacci, S.; Toteda, G.; Vizza, D.; Perri, A.; Benincasa, C.; Mollica, A.; La Russa, A.; Gigliotti, P.;
Leone, F.; Lofaro, D.; et al. Active Compounds Extracted From Extra Virgin Olive Oil Counteract
Mesothelial-To-Mesenchymal Transition of Peritoneal Mesothelium Cells Exposed to Conventional Peritoneal
Dialysate: In Vitro and in Vivo Evidences. J. Nephrol. 2017, 30, 841–850. [CrossRef]
88. Riesenhuber, A.; Kasper, D.C.; Vargha, R.; Endemann, M.; Aufricht, C. Quercetin protects human mesothelial
cells against exposure to peritoneal dialysis fluid. Pediatr. Nephrol. 2007, 22, 1205–1208. [CrossRef]
89. Lin, C.; Sun, X.; Lin, A. Supplementation with high-dose trans-resveratrol improves ultrafiltration in
peritoneal dialysis patients: A prospective, randomized, double-blind study. Renal Fail. 2016, 38, 214–221.
[CrossRef]
90. Firuzi, O.; Khajehrezaei, S.; Ezzatzadegan, S.; Nejati, M.; Jahanshahi, K.-A.; Roozbeh, J. Effects of silymarin on
biochemical and oxidative stress markers in end-stage renal disease patients undergoing peritoneal dialysis.
Hemodial. Int. 2016, 20, 558–563. [CrossRef]
91. Singh, R.G.; Negi, P.S.; Radha, C. Phenolic composition, antioxidant and antimicrobial activities of free and
bound phenolic extracts of Moringaoleifera seed flour. J. Funct. Foods 2013, 5, 1883–1891. [CrossRef]
92. Adisakwattana, S.; Ruengsamran, T.; Kampa, P.; Sompong, W. In vitro inhibitory effects of plant-based foods
and their combinations on intestinal-glucosidase and pancreatic-amylase. BMC Complement. Altern. Med.
2012, 12, 110. [CrossRef] [PubMed]
93. Alhamdani, M.S.; Al-Azzawie, H.F.; Abbas, F.K. Decreased formation of advanced glycation end-products in
peritoneal fluid by carnosine and related peptides. Perit. Dial. Int. 2007, 27, 86–89. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
